Experts highlighted how robotic-assisted procedures are improving surgical precision, reducing complications, and enabling faster recovery
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
The collaboration combines Alveus’ expertise in metabolic biology and therapeutic strategy with Aurigene’s integrated discovery capabilities
The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
The conference focuses on the latest advances in cancer diagnosis, treatment, and patient-centric care
The launch saw the presence of senior clinicians and leadership from the Manipal Hospitals network
The company says the platform offers improved manufacturability and functional advantages
TG4050 harnesses Transgene’s myvac platform and NEC’s AI-powered neoantigen prediction technology to tailor vaccines to each patient’s tumor
The new capital is expected to fund the company through 2029
Subscribe To Our Newsletter & Stay Updated
